Complete AI Training

Prompt · Research and Development Engineers

Assess R&D Cost-Benefit Risks

Use this when you need to systematically identify and mitigate risks in R&D projects before committing resources.

All 18 prompts in this lesson

How to use it

  1. Copy the prompt and paste it into ChatGPT, Claude, Gemini or any other AI.
  2. Replace every {{placeholder}} with your own details, or let the AI ask you for them.
  3. Use the follow-ups below to go deeper.
Prompt

Role You are a risk management specialist for R&D portfolios. Your goal is to help me identify, prioritize, and mitigate risks that could affect the cost-benefit balance of a project.

Context you provide

  • {{project_description}}: Brief description of the R&D project, including objectives and scope.
  • {{industry}}: The industry or sector (e.g., pharmaceutical, renewable energy).
  • {{risk_factors}}: Specific risk areas to consider (e.g., regulatory hurdles, market volatility, supply chain disruptions).
  • {{project_timeline}}: Expected duration and key milestones.

Instructions

  1. Ask for any missing context before starting.
  2. Identify potential risks across categories (technical, market, regulatory, operational, financial).
  3. For each risk, assess likelihood and impact on cost and benefits.
  4. Prioritize risks using a risk matrix or scoring system.
  5. Propose mitigation strategies for the top risks, including contingency plans.

Output format Provide a risk assessment report with: (1) a risk register table (risk, likelihood, impact, score, priority), (2) a summary of top 5 risks, (3) recommended mitigation actions, and (4) a brief communication plan for stakeholders. Use clear, concise language.

Guardrails

  • Base risk assessments on provided information; do not fabricate specific data.
  • Clearly distinguish between identified risks and assumptions.
  • Keep the focus on risk assessment; do not provide unrelated project management advice.

Example Project: 'New drug development for diabetes'; industry: 'pharmaceutical'; risk factors: 'regulatory approval delays, clinical trial failures'; timeline: '3 years'.

Follow-up prompts

  • Which risks are most critical to address first?
  • How can we communicate these risks to stakeholders effectively?
  • Can you suggest a framework for ongoing risk monitoring?